Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Serota

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Toxicology|December 24, 2019
History of the American College of Toxicology: The 15-Year Period From 2004 Through 2018David G Serota
International Journal of Toxicology|April 12, 2023
Putting a Face on ResearchDavid G Serota
Toxicology and Industrial Health|June 22, 2026
The history of the Toxicology Roundtable-75 years of scientific discussionDavid G Serota, Christopher N Papagiannis
Nutrition and Cancer|February 18, 2003
Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrateX Steven Wan, David G Serota, Jeffrey H Ware, et al.
International Immunopharmacology|April 12, 2003
Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2'-deoxyguanosine in primatesJ Michael Kilpatrick, Philip E Morris, David G Serota, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamideN Germann, S Urien, Andrew H Rodgers, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Toxicology|December 24, 2019
History of the American College of Toxicology: The 15-Year Period From 2004 Through 2018David G Serota
International Journal of Toxicology|April 12, 2023
Putting a Face on ResearchDavid G Serota
Toxicology and Industrial Health|June 22, 2026
The history of the Toxicology Roundtable-75 years of scientific discussionDavid G Serota, Christopher N Papagiannis
Nutrition and Cancer|February 18, 2003
Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrateX Steven Wan, David G Serota, Jeffrey H Ware, et al.
International Immunopharmacology|April 12, 2003
Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2'-deoxyguanosine in primatesJ Michael Kilpatrick, Philip E Morris, David G Serota, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamideN Germann, S Urien, Andrew H Rodgers, et al.
Pageof 1